Tuberculosis after commencing antiretroviral therapy for HIV infection is associated with elevated CXCL9 and CXCL10 responses to Mycobacterium tuberculosis antigens.

QR Code

Tuberculosis after commencing antiretroviral therapy for HIV infection is associated with elevated CXCL9 and CXCL10 responses to Mycobacterium tuberculosis antigens.

Background: Commencing antiretroviral therapy (ART) in human immunodeficiency virus-infected patients with treated or unrecognized Mycobacterium tuberculosis disease may trigger tuberculosis-associated immune reconstitution inflammatory syndrome (TB-IRIS) or ART-associated tuberculosis (ART-TB). We...

Full description

Bibliographic Details
Main Authors:	Oliver, B., Elliott, J., Price, Patricia, Phillips, M., Cooper, D., French, M.
Format:	Journal Article
Published:	Lippincott Williams & Wilkins 2012
Online Access:	http://hdl.handle.net/20.500.11937/57014

Similar Items

The search for biomarkers of immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy
by: Oliver, B., et al.
Published: (2011)

Mediators of innate and adaptive immune responses differentially affect immune restoration disease associated with Mycobacterium tuberculosis in HIV patients beginning antiretroviral therapy
by: Oliver, B., et al.
Published: (2010)

Pre-antiretroviral therapy plasma levels of CCL2 may aid in the prediction of tuberculosis-associated immune reconstitution inflammatory syndrome in HIV patients after they commence antiretroviral therapy
by: Oliver, B., et al.
Published: (2013)

Increased plasma CXCL10 may be a marker of increased risk of immune restoration disease associated with nonviral pathogens
by: Oliver, B., et al.
Published: (2012)

Short communication: Plasma levels of vitamin D in HIV patients initiating antiretroviral therapy do not predict immune restoration disease associated with mycobacterium tuberculosis
by: Price, Patricia, et al.
Published: (2012)

Interferon-? and IL-5 production correlate directly in HIV patients Co-infected with mycobacterium tuberculosis with or without immune restoration disease
by: Oliver, B., et al.
Published: (2010)

Interplay between EZH2 and G9a regulates CXCL10 gene repression in idiopathic pulmonary fibrosis
by: Coward, William R., et al.
Published: (2017)

Active and Persistent Cytomegalovirus Infections Affect T Cells in Young Adult HIV Patients Commencing Antiretroviral Therapy
by: Ariyanto, I., et al.
Published: (2018)

Few Liver-Infiltrating Cells Express CXCR3 in HIV/HCV Patients Commencing Antiretroviral Therapy.
by: Marini, S., et al.
Published: (2016)

Molecular genotyping of mycobacterium tuberculosis associated with extrapulmonary tuberculosis
by: Ayub, Nur Izzah Farakhin
Published: (2015)

The search for a genetic factor associating with immune restoration disease in HIV patients co-infected with Mycobacterium tuberculosis
by: Affandi, J., et al.
Published: (2013)

Plasma biomarkers in the prediction and diagnosis of tuberculosis-associated immune reconstitution inflammatory syndrome
by: French, M., et al.
Published: (2011)

Isolation of RNA aptamers specific toward 16 KDA mycobacterium tuberculosis antigen protein
by: Mohammed, Nurul Adila
Published: (2020)

p-Hydroxybenzoic acid synthesis in mycobacterium tuberculosis
by: Stadthagen, Gustavo, et al.
Published: (2005)

Evaluation of interferon gamma release assay using mycobacterium tuberculosis antigens for diagnosis of pulmonary tuberculosis in BCG vaccinated population of Kelantan, Malaysia
by: Hajar Fauzan, Ahmad
Published: (2013)

Evaluation of interferon gamma release assay using Mycobacterium tuberculosis antigens for diagnosis of pulmonary tuberculosis in bcg vaccinated population of Kelantan, Malaysia
by: Ahmad, Hajar Fauzan
Published: (2013)

Immune restoration disease complicating antiretroviral therapy in patients with HIV infection: Implications and solutions
by: French, M., et al.
Published: (2008)

Electrochemical immunosensor for detection of Mycobacterium tuberculosis
by: Mohd Azmi, Umi Zulaikha, et al.
Published: (2018)

Epigenetic dysregulation of interleukin 8 (CXCL8) hypersecretion in cystic fibrosis airway epithelial cells
by: Poghosyan, Anna, et al.
Published: (2016)

Evaluation of CXCL10 as potential biomarker for early detection of severe dengue / Siti Noraihan Khamis
by: Khamis, Siti Noraihan
Published: (2019)

Comparison Of Proteomes Of Avirulent Mycobacterium Tuberculosis H37Ra And Virulent Mycobacterium Tuberculosis H37Rv
by: Ang, Kai Cheen
Published: (2011)

Reply to 'TLR-2 ligand lipomannan from Mycobacterium tuberculosis does not stimulate inflammatory cytokines in dendritic cells'
by: Tan, D., et al.
Published: (2012)

Modulation of the immune response to Mycobacterium tuberculosis during malaria/M. tuberculosis co-infection
by: Chukwuanukwu, Rebecca C., et al.
Published: (2016)

Molecular dynamics simulations of CXCL-8 and its interactions with a receptor peptide, heparin fragments and sulfated cyclitols.
by: Gandhi, Neha, et al.
Published: (2011)

Comparative genomic analysis of Mycobacterium tuberculosis in lung and meningeal tuberculosis / Syakirah Nurizzati Mohamad Hood
by: Syakirah Nurizzati , Mohamad Hood
Published: (2019)

Construction of plasmids expressing specific genes of Mycobacterium tuberculosis: towards the development of vaccine against tuberculosis
by: Musa, Mustaffa, et al.
Published: (2001)

Immunogenicity of recombinant mycobacterium smegmatis expressing antigen 85b epitopes as a potential tuberculosis vaccine candidate
by: Kadir , Nur Ayuni
Published: (2017)

Synthesis of Potential Mycobacterium Tuberculosis InhA Inhibitors
by: Saleem, Tabrez Ali
Published: (2023)

Kinase Targets for Mycolic Acid Biosynthesis in Mycobacterium tuberculosis.
by: Alsayed, S., et al.
Published: (2018)

Coenzyme F420 biosynthesis proteins in Mycobacterium tuberculosis
by: Mohamed Rehan, Aisyah, et al.
Published: (2009)

Indoleamides are active against drug-resistant Mycobacterium tuberculosis
by: Lun, S., et al.
Published: (2013)

Electrochemical and optical-based immunosensor for detection of Mycobacterium tuberculosis
by: Mohd Bakhori, Noremylia
Published: (2019)

Respiratory microbiome and its susceptibility to Mycobacterium tuberculosis infection
by: Semail, Noreafifah
Published: (2019)

Cloning and characterization of mycobacterium tuberculosis katG gene
by: Martin, Eugene Ray
Published: (2005)

The cloning and chcracterization of mycobacterium tuberculosis katG gene
by: Martin, Eugene Ray
Published: (2005)

Tuberculosis associated immune reconstitution inflammatory syndrome in patients infected with HIV: meningitis a potentially life threatening manifestation
by: Agarwal, U., et al.
Published: (2012)

Development of recombinant Mycobacterium smegmatis (MS) expressing B- and T-cell epitopes of latency associated antigens of Mycobacterium tuberculosis (MTB) as a TB vaccine candidate
by: Ismail, Mohd Zakuan
Published: (2017)

The Development Of A Candidate Tuberculosis Dna Vaccine Expressing MtbS.4 And Ag858 of Mycobacterium Tuberculosis
by: Azlan, Maryam
Published: (2007)

Molecular mechanisms of enhanced expression of the chemokine interleukin 8 (CXCL8) in cystic fibrosis (CF) airway epithelial cells
by: Poghosyan, Anna
Published: (2014)

Pharmacologically antagonizing the CXCR4-CXCL12 chemokine pathway with AMD3100 inhibits sunlight-induced skin cancer
by: Sarchio, Seri Narti Edayu, et al.
Published: (2014)